Comprehensive Study Guide: Managing First-Line and Treatment-Resistant OCD

Clinical Overview and Diagnostic Criteria of Obsessive-Compulsive Disorder (OCD)

• DSM-5 Definition and Core Features

  • OCD is characterized by the presence of obsessions, compulsions, or both.

  • Obsessions: Defined as recurrent and persistent thoughts, urges, or images that are experienced as intrusive and unwanted. These cause significant anxiety or distress. Individuals attempt to ignore, suppress, or neutralize them through other thoughts or actions (compulsions).

  • Compulsions: Repetitive behaviors (e.g., handwashing, ordering, checking) or mental acts (e.g., counting, praying, repeating words silently) the individual feels driven to perform in response to an obsession or according to rigid rules.

  • The goal of compulsions is to reduce anxiety or prevent a feared event, though they are not realistically connected to the event they aim to prevent.

• Diagnostic Thresholds

  • Symptoms must be time-consuming, typically defined as taking up more than $1\,\text{hour}$ per day.

  • Symptoms must cause significant distress or impairment in social, occupational, or other functional areas.

  • Symptoms must not be attributable to the physiological effects of a substance or a medical condition and are not better explained by another mental disorder.

• Insight Specifiers

  • Good/Fair Insight: The individual recognizes that OCD beliefs are definitely or probably not true.

  • Poor Insight: The individual thinks OCD beliefs are probably true.

  • Absent Insight/Delusional Beliefs: The individual is completely convinced that OCD beliefs are true (e.g., believing a repetitive action can prevent a natural disaster).

  • Tic-Related: The individual has a current or past history of a tic disorder, which frequently co-occurs with OCD.

Epidemiology and Differential Diagnosis

• Prevalence and Comorbidity

  • Lifetime prevalence worldwide is estimated at $1.5\%$ for women and $1.0\%$ for men.

  • Commonly comorbid with anxiety disorders, depression, and tic disorders.

• Medical Rule-Out and Neurological Considerations

  • OCD symptoms can be early manifestations of neurological conditions.

  • Timeline is Critical: Rapid onset may suggest an underlying medical issue, whereas lifetime symptoms with periodic worsening often suggest a primary psychiatric etiology.

  • Dementia/Alzheimer’s: OCD symptoms may be an early sign of dementia rather than a complication of pre-existing OCD.

  • Physical Symptoms to Monitor: Tremors, seizures, loss of consciousness, or confusion should prompt neurological investigation.

  • Anti-NMDA Receptor Encephalitis: A rare medical condition (referenced in the book Brain on Fire) that can present with rapid-onset psychosis and OCD-like symptoms; clues include unexplained physical symptoms like urinary incontinence or headaches.

  • PANDAS: Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections. This is a controversial, post-infectious diagnosis. Suspected cases should be referred to specialized centers as many general practitioners do not treat it due to its complexity.

Clinical Presentation: Real-World Case Studies

• Decision-Making Compulsion: A young adult who flipped a coin roughly $100$ times per day for even minor decisions like choosing sock colors.

• Sensory/Ritualistic Patterns: A teenager who felt driven to hold her mother's hand in a specific orientation (on top) despite causing pain to the mother; the child also required a specific number of reassurances regarding death.

• Symmetry and Rigidity: A teenager with a rigid bedtime routine involving washing her face exactly $10$ times. When routines were disrupted (e.g., during vacation), she experienced hours of screaming and insomnia.

• Protective Rituals: A mother who felt compelled to circle her children's school a specific number of times after drop-off to prevent a school shooting.

• Intrusive Sexual Thoughts: An adult male terrified of becoming a pedophile or changing sexual orientation despite having no attraction to children or men. This caused extreme shame and distress.

• Somatic Obsessions: A young adult with an urge to repetitively swallow saliva and count each swallow. This was differentiated from a tic because the patient felt a conscious "drive" to perform the act rather than it being an involuntary movement.

First-Line Pharmacological Interventions

• Selective Serotonin Reuptake Inhibitors (SSRIs)

  • FDA-approved for OCD: Fluoxetine (Prozac), Fluvoxamine (Luvox), Sertraline (Zoloft), and Paroxetine (Paxil).

  • Luvox (Fluvoxamine):

    • FDA approved for ages $8+$ for OCD.

    • Adult Starting Dose: $50\,\text{mg}$ at bedtime.

    • Titration: Increase by $50\,\text{mg}$ every $4$ to $7$ days as tolerated.

    • Max Dose: $300\,\text{mg/day}$ (Daily doses over $100\,\text{mg}$ should be divided).

    • Pediatric Starting Dose: $25\,\text{mg}$; Max for teens is approximately $250\,\text{mg}$.

    • Side Effects: GI upset, headache, sedation at higher doses.

  • Zoloft (Sertraline):

    • FDA approved for ages $6+$ for OCD.

    • Adult Starting Dose: $50\,\text{mg/day}$.

    • Max Dose: $200\,\text{mg/day}$.

    • Pediatric Dose: $25\,\text{mg}$ for ages $6$-$12$; $50\,\text{mg}$ for ages $13$-$17$.

    • Clinical Pearls: Effective for co-occurring PTSD or depression. Monitor for low libido, emotional blunting, and tremors at high doses.

  • Prozac (Fluoxetine):

    • FDA approved for ages $7+$ for OCD.

    • Adult Starting Dose: $20\,\text{mg/day}$.

    • Max Dose: $80\,\text{mg/day}$.

    • Side Effects: Activation, insomnia, GI upset.

    • Clinical Pearl: Best for patients worried about sedation or significant weight gain; generally seen to have fewer sexual side effects compared to other SSRIs.

• General Dosing Principle: OCD typically requires higher doses of SSRIs than MDD to achieve symptom relief. Practitioners should warn patients that multiple increases may be necessary.

First-Line Non-Pharmacological and Integrative Interventions

• Exposure Response Prevention (ERP)

  • A specific type of Cognitive Behavioral Therapy (CBT) and the gold standard for OCD.

  • Process: Exposure to fear-eliciting stimuli in a hierarchical manner while preventing the subsequent compulsion.

  • Goals of ERP:

    1. Habituation: Natural reduction of anxiety over time through repeated exposure.

    2. Inhibitory Learning: Learning that feared outcomes do not happen and that distress is tolerable.

    3. Cognitive Restructuring: Developing adaptive beliefs about fears.

  • Efficacy: $60$-$80\%$ of patients show significant reduction, maintaining gains for at least $5$ years.

• Integrative Strategies

  • N-Acetylcysteine (NAC): Titrate up to $1500\,\text{mg}$ BID (Max $3000\,\text{mg/day}$ for adults). Especially effective for skin-picking, trichotillomania, and OCD in autistic patients.

  • Glycine: Studied up to $60\,\text{g/day}$ as adjunctive treatment; however, nonadherence is high due to nausea and poor taste.

  • Inositol: May act as a booster for SSRIs; studied up to $18\,\text{g/day}$.

  • Lifestyles: Exercise, Mindfulness-Based Stress Reduction (MBSR), and Kundalini yoga have shown clinical benefits.

Part 2: Definition and Management of Treatment-Resistant OCD

• Definition of Treatment Resistance

  • Inadequate response to failure of two or more trials of SSRIs or SNRIs at maximum tolerable doses.

  • Includes failure of an adequate ERP trial (often defined as at least $20$-$30$ hours of therapy).

  • Assessment Checklist: Ensure medication compliance, verify the diagnosis, and address untreated comorbidities.

• SNRIs in OCD

  • None are FDA approved for OCD; they are used off-label.

  • Pristiq (Desvenlafaxine): Preferred due to tolerability over Effexor. Often used if a family member responded well to an SNRI or if the patient prefers it over TCAs.

• Clomipramine (Anafranil)

  • FDA approved for OCD for ages $10+$.

  • Mechanism: Tricyclic Antidepressant (TCA).

  • Starting Dose: $25\,\text{mg/day}$. Titrate by $25\,\text{mg}$ every $4$ to $7$ days (though $2$-$4$ weeks is safer).

  • Max Dose: $250\,\text{mg/day}$.

  • Safety Warning: Lethal in overdose. Avoid in patients with active or chronic suicidality.

  • Side Effects: Significant dry mouth, dizziness, weight gain, and cardiovascular effects.

  • Monitoring: ECGs are recommended for high doses or patients with cardiac history.

• Antipsychotic Augmentation

  • Used only as adjuncts to SSRIs; not recommended as monotherapy.

  • Best Evidence: Risperdal (Risperidone) and Abilify (Aripiprazole).

  • Mixed Evidence: Seroquel, Zyprexa, and Haldol.

  • Choice of agent should depend on comorbidities (e.g., Seroquel for insomnia, Risperdal for agitation).

Treatment Algorithms and Advanced Procedures

• Neuromodulation

  • TMS (Transcranial Magnetic Stimulation): FDA-cleared for treatment-resistant OCD.

  • DBS (Deep Brain Stimulation): Reserved for the most severe, refractive cases.

• Structured Treatment Algorithm

  1. First trial: High-dose SSRI + ERP + Integrative interventions.

  2. If minimal effect: Switch to a second high-dose SSRI.

  3. If partial response: Augment with an antipsychotic or Clomipramine.

  4. If no response to SSRIs: Trial Clomipramine monotherapy.

  5. Pediatric Note: Always investigate triggers like PANDAS/PANS and treat co-occurring tics simultaneously.

• Genetic Testing (GeneSight)

  • Useful in treatment-resistant cases to identify metabolic issues or sensitivities (e.g., a patient experiencing severe dizziness on low-dose Clomipramine may have a genetic interaction).